Your browser doesn't support javascript.
loading
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma.
Shouse, Geoffrey; Kaempf, Andy; Gordon, Max J; Artz, Andy; Yashar, David; Sigmund, Audrey M; Smilnak, Gordon; Bair, Steven M; Mian, Agrima; Fitzgerald, Lindsey A; Bajwa, Amneet; Jaglowski, Samantha; Bailey, Neil; Shadman, Mazyar; Patel, Krish; Stephens, Deborah M; Kamdar, Manali; Hill, Brian T; Gauthier, Jordan; Karmali, Reem; Nastoupil, Loretta J; Kittai, Adam S; Danilov, Alexey V.
Afiliação
  • Shouse G; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
  • Kaempf A; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
  • Gordon MJ; Department of Lymphoma, MD Anderson Cancer Center, Houston, TX.
  • Artz A; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
  • Yashar D; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
  • Sigmund AM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.
  • Smilnak G; Division of Hematology/Oncology, Northwestern University, Chicago, IL.
  • Bair SM; University of Colorado Cancer Center, University of Colorado, Aurora, CO.
  • Mian A; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Fitzgerald LA; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.
  • Bajwa A; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.
  • Jaglowski S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.
  • Bailey N; Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA.
  • Shadman M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Patel K; Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA.
  • Stephens DM; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.
  • Kamdar M; University of Colorado Cancer Center, University of Colorado, Aurora, CO.
  • Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Karmali R; Division of Hematology/Oncology, Northwestern University, Chicago, IL.
  • Nastoupil LJ; Department of Lymphoma, MD Anderson Cancer Center, Houston, TX.
  • Kittai AS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.
  • Danilov AV; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
Blood Adv ; 7(14): 3516-3529, 2023 07 25.
Article em En | MEDLINE | ID: mdl-36735393
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article